Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...
Ladenburg Healthcare Conference Presentation
Tuesday, September 26, 2017 @ 11:00 a.m. ET